Browse by all authors Browse By Author ID - Serisier, David J.

Browse Results (46 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Chen, Alice C.-H., Martin, Megan L., Lourie, Rohan, Rogers, Geraint B., Burr, Lucy D., Hasnain, Sumaira Z., Bowler, Simon D., McGuckin, Michael A. and Serisier, David J. (2015) Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS ONE, 10 3: . doi:10.1371/journal.pone.0119325 12 3 0 Cited 0 times in Scopus0 2
Serisier, D. J., Wong, R. C. W. and Armstrong, J. G. (2006) Alveolar haemorrhage in anti-glomerular basement membrane disease without detectable antibodies by conventional assays. Thorax, 61 7: 636-639. doi:10.1136/thx.2004.028985 73   11 Cited 12 times in Scopus12 0
Rogers, Geraint B., Zain, Nur Masirah M., Bruce, Kenneth D., Burr, Lucy D., Chen, Alice C., Rivett, Damian W., McGuckin, Michael A. and Serisier, David J. (2014) A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Annals of the American Thoracic Society, 11 4: 496-503. doi:10.1513/AnnalsATS.201310-335OC 25   Cited 16 times in Scopus16 2
Serisier, D.J., Tuck, A., Matley, D., Carroll, M.P. and Jones, G. (2012) Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing. European Journal of Clinical Microbiology and Infectious Diseases, 31 11: 3211-3216. doi:10.1007/s10096-012-1687-6 42   1 Cited 2 times in Scopus2 1
Bowler, S., Serisier, D., Schollay, D., O'Rourke, P. K., Nicholson, C., Tweedale, M. and Jackson, C. L. (2001) A pilot study comparing substitutable care at home with usual hospital care acute Chronic Obstructive Pulmonary Disease. Final report to National Demonstration Hospital Program Brisbane: School of Population Health 88  
Serisier, David J., Williams, Sophie and Bowler, Simon D. (2013) Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia. Respirology, 18 2: 291-296. doi:10.1111/j.1440-1843.2012.02275.x 53   6 Cited 9 times in Scopus9 0
Rogers, Geraint B., Carroll, Mary P., Serisier, David J., Hockey, Peter M., Kehagia, Valia, Jones, Graeme R. and Bruce, Kenneth D. (2005) Bacterial activity in cystic fibrosis lung infections. Respiratory Research, 6 . doi:10.1186/1465-9921-6-49 33   49 Cited 52 times in Scopus52 0
Serisier, D. J., Singh, M. and Bowler, S. D. (2005) Bronchial beetle. Thorax, 60 3: 262-262. doi:10.1136/thx.2004.037770 18   0 Cited 0 times in Scopus0 0
Serisier, D. J. and Carroll, M. P. (2006) Catheter-related thrombosis associated with elevated factor VIII levels in cystic fibrosis. Journal of Cystic Fibrosis, 5 3: 201-204. doi:10.1016/j.jcf.2006.02.003 34   2 Cited 3 times in Scopus3 0
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G. and Bruce, K. D. (2004) Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. Journal of Clinical Microbiology, 42 11: 5176-5183. doi:10.1128/JCM.42.11.5176-5183.2004 39   146 Cited 162 times in Scopus162 0
Serisier, DJ, Jones, G, Tuck, A, Connett, G and Carroll, MP (2003) Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis. Pediatric Pulmonology, 35 6: 463-466. doi:10.1002/ppul.10294 21   5 Cited 5 times in Scopus5 0
Chen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. In: Respirology. , , (88-88). . 27   0
Rogers, G.B., Van Der Gast, C.J., Cuthbertson, L., Thomson, S.K., Bruce, K.D., Martin, M.L. and Serisier, D.J. (2013) Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax, 68 8: 731-737. doi:10.1136/thoraxjnl-2012-203105 13   24 Cited 30 times in Scopus30 4
McCormack, J. G., Bell, S. C., Senini, S., Walmsley, K., Patel, K., Wainwright, C., Serisier, D., Harris, M. and Bowler, S. (2007) Daily versus weekly azithromycin in cystic fibrosis patients.. European Respiratory Journal, 30 3: 487-495. doi:10.1183/09031936.00163306 121   30 Cited 29 times in Scopus29 0
Rogers, Geraint B., Skelton, Stuart, Serisier, David J., van der Gast, Christopher J. and Bruce, Kenneth D. (2010) Determining cystic fibrosis-affected lung microbiology: Comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. Journal of clinical microbiology, 48 1: 78-86. doi:10.1128/JCM.01324-09 87   26 Cited 24 times in Scopus24 0
Rogers, G., Chen, A., Burr, L. and Serisier, D. (2014). Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis. In: Respirology. , , (30-30). . 16   0
Serisier, David J., Coates, Andrew D. and Bowler, Simon D. (2007) Effect of albuterol on maximal exercise capacity in cystic fibrosis. Chest, 131 4: 1181-1187. doi:10.1378/chest.06-1697 109   8 Cited 7 times in Scopus7 0
Serisier, D. J. and Bowler, S. (2007) Effect of a simple educational intervention on the hospital management of community-acquired pneumonia. Respirology, 12 3: 389-393. doi:10.1111/j.1400-1843.2007.01058.x 50   4 Cited 5 times in Scopus5 0
Serisier, David J., Martin, Megan L., McGuckin, Michael A., Lourie, Rohan, Chen, Alice C., Brain, Barbara, Biga, Sally, Schlebusch, SanmariĆ©, Dash, Peter and Bowler, Simon D. (2013) Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA: The Journal of the American Medical Association, 309 12: 1260-1267. doi:10.1001/jama.2013.2290 74   67 Cited 79 times in Scopus79 26
Fielding, David, Hopkins, Peter and Serisier, David (2005) Frozen section of pleural biopsies at medical thoracoscopy assists in correctly identifying benign disease. Respirology, 10 5: 636-642. doi:10.1111/j.1440-1843.2005.00761.x 39   7 Cited 9 times in Scopus9 0
Brown, JM and Serisier, DJ (2000) Guidewire-induced trauma after percutaneous tracheostomy. Anaesthesia and Intensive Care, 28 6: 704-705. 14   0
Chen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. In: Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, (87-87). 4-9 April 2014. doi:10.1111/resp.12263_6 28   0 0
Visser, S., Martin, M. and Serisier, D. J. (2012) Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report. Lung, 190 5: 579-581. doi:10.1007/s00408-012-9393-9 26   2 Cited 2 times in Scopus2 2
Serisier, D. J. (2012) Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin. Drugs of Today, 48 5: 339-351. doi:10.1358/dot.2012.48.5.1789474 88 3 8 Cited 11 times in Scopus11 0
Serisier, David J., Bilton, Diana, De Soyza, Anthony, Thompson, Philip J., Kolbe, John, Greville, Hugh W., Cipolla, David, Bruinenberg, Paul and Gonda, Igor (2013) Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax, 68 9: 812-817. doi:10.1136/thoraxjnl-2013-203207 24   36 Cited 46 times in Scopus46 7
Serisier, D. J., Shute, J. K., Hockey, P. M., Higgins, B., Conway, J. and Carroll, M. P. (2006) Inhaled heparin in cystic fibrosis. European Respiratory Journal, 27 2: 354-358. doi:10.1183/09031936.06.00069005 19   9 Cited 11 times in Scopus11 0
Bowler, Simon and Serisier, David (2011) Letter: Single maintenance and reliever therapy. Thorax, 66 1: 87-87. doi:10.1136/thx.2010.150219 23   3 Cited 3 times in Scopus3 0
Serisier, D. J., Wong, R. C. W. and Armstrong, J. G. (2006) Letter to the editor: Diffuse alveolar haemorrhage in a young male smoker: A word of caution. Internal Medicine Journal, 36 9: 621-621. doi:10.1111/j.1445-5994.2006.01164.x 45   0 Cited 0 times in Scopus0 0
Serisier, D. J. and Martin, M. L. (2011) Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respiratory Medicine, 105 6: 946-949. doi:10.1016/j.rmed.2011.01.009 54   29 Cited 39 times in Scopus39 0
Serisier, David J., Carroll, Mary P., Shute, Janis K. and Young, Simon A. (2009) Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease and normal sputum. Respiratory Research, 10 63: 63-1-63-8. doi:10.1186/1465-9921-10-63 48   6 Cited 8 times in Scopus8 0
Gray, T. J., Serisier, D. J., Gilpin, C. M., Coulter, C., Bowler, S. and McCormack, J. G. (2007) Nocardia Paucivorans - A cause of disseminated Nocardiosis. Journal of Infection, 54 2: 95-98. doi:10.1016/j.jinf.2006.05.005 96   Cited 5 times in Scopus5 0
Mubarak, V, Bowler, S, Serisier, D and Mcguckin, M (2011). Pepsin as a Marker of Aspiration in the Exhaled Breath Condensate of Patients with Cystic Fibrosis: a Pilot Study. In: Respirology. Unknown, unknown, (9-10). unknown. 37   0
Rogers, Geraint B., van der Gast, Christopher J. and Serisier, David J. (2015) Predominant pathogen competition and core microbiota divergence in chronic airway infection. ISME Journal, 9 1: 217-225. doi:10.1038/ismej.2014.124 13   1 Cited 2 times in Scopus2 3
Visser, S., Burr, L., Rogers, G. and Serisier, D. (2014). Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study. In: Respirology. , , (112-112). . 23   0
Tazbirkova, A, Bryant, G, Bowler, S, Serisier, D and Lwin, Z (2011). Radiation Induced Injury Resulting in Life-Threatening Hypercapnic Respiratory Failure, Perforated Oesophagitis and Pneumomediastinum: a Case Report. In: Journal of Thoracic Oncology. Unknown, unknown, (S1460-S1461). unknown. 37   0
Serisier, D. J. and Bowler, S. D. (2012) Randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis . . . without patient blinding. American Journal of Respiratory and Critical Care Medicine, 186 5: 461-461. 38   1 Cited 0 times in Scopus0
Teo, C., Nakaji, P., Serisier, D. and Coughlan, M. (2005) Resolution of trigeminal neuralgia following third ventriculostomy for hydrocephalus associated with Chiari I malformation: case report. Minimally Invasive Neurosurgery, 48 5: 302-305. doi:10.1055/s-2005-915597 39   9 Cited 10 times in Scopus10 0
Rogers, Geraint B., Shaw, Dominick, Marsh, Robyn L., Carroll, Mary P., Serisier, David J. and Bruce, Kenneth D. (2014) Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax, 70 1: 74-81. doi:10.1136/thoraxjnl-2014-205826 10   Cited 3 times in Scopus3 13
Serisier, D.J. (2013) Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. The Lancet Respiratory Medicine, 1 3: 262-274. doi:10.1016/S2213-2600(13)70038-9 39 3 Cited 29 times in Scopus29 15
Bruinenberg, P., Serisier, D., Cipolla, D. and Blanchard, J. (2010). Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. In: Pediatric Pulmonology. unknown, unknown, (354-354). unknown. 43   3
Kidd, Timothy J., Ramsay, Kay A., Hu, Honghua, Marks, Guy B., Wainwright, Claire E., Bye, Peter T., Elkins, Mark R., Robinson, Philip J., Rose, Barbara R., Wilson, John W., Grimwood, Keith, Bell, Scott C., ACPinCF Investigator Group, Serisier, David J. and Smith, Daniel J. (2012) Shared pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. European Respiratory Journal, 41 5: 1091-1100. doi:10.1183/09031936.00060512 50   11 Cited 12 times in Scopus12 7
Ling, V.Y.-M., Mortimore, M. and Serisier, D.J. (2013) Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: Case report. SpringerPlus, 2 1: 1-4. doi:10.1186/2193-1801-2-101 20 1 Cited 2 times in Scopus2 0
Wainwright, C., Bell, S., Morton, J., Ryan, G., Serisier, D., Bye, P., Mulrennan, S., Daley, C. and Greville, H. (2014). The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient Programme. In: Respirology. , , (112-112). . 38   0
Rogers, Geraint B., Bruce, Kenneth D., Martin, Megan L., Burr, Lucy D. and Serisier, David J. (2014) The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. The Lancet Respiratory Medicine, 2 12: 988-996. doi:10.1016/S2213-2600(14)70213-9 32   3 Cited 4 times in Scopus4 5
Semple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. In: P. J. Thompson, Respirology.. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, (A80-A80). 18-23 March, 2005. doi:10.1111/j.1440-1843.2005.00663.x-i1 64   0
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., Kehagia, V., Connett, G. J. and Bruce, K. D. (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. Journal of Clinical Microbiology, 44 7: 2601-2604. doi:10.1128/JCM.02282-05 29   68 Cited 80 times in Scopus80 0